StemCells to acquire subsidiaries, assets of U.K. biotech firm

03/2/2009 | American City Business Journals

London-based Stem Cell Sciences has agreed to sell its operating units and certain related assets to StemCells for about $715,000 in cash and 2.65 million shares of stock. The deal, which was cleared by both firms' boards of directors, covers stem cell technologies as well as expertise and infrastructure for cell-based assays used in treatment discovery and testing.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr Statistician I (US/TB/00/0028/SL)
Abbott
Santa Clara, CA
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA